Comprehensive Symptom Assessment of ICU Patients Receiving Noninvasive Ventilation

Overview

About this study

The primary objective of this study is to identify the presence, intensity and distress of symptoms in patients receiving noninvasive ventilation in the ICU using a modified version the Edmonton Symptom Assessment Scale (ESAS).

The secondary objective is to describe the most frequent and most distressing symptoms experienced by patients receiving NIV in the ICU.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Receiving NIV for acute illness and/or active physician order for NIV; NIV defined as a tight-fitting mask delivering positive airway pressure
  • Willing and able to participate and follow commands
  • English speaking
  • Admitted to the participating Intensive Care Unit

Exclusion Criteria:

  • Severe cognition or communication problems (i.e., documented dementia, severe altered mental capacity)
  • Use of personal NIV equipment for non-acute diagnoses while in the ICU, such as sleep apnea
  • Prisoners

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Linda Chlan, Ph.D., R.N.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions